Dr. Andrew R. Barleben, MD, MPH

Dr. Barleben practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Barleben's NPI, 1497936900, was assigned on November 27, 2007. Dr. Barleben graduated from New York Medical College in 2005. Dr. Barleben holds California license A99417.

Dr. Barleben's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Barleben's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Barleben is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Barleben to 5 more hospitals, 1 group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Barleben practices, 8 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Barleben's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Barleben is board certified in surgery by the American Board of Surgery. Dr. Barleben is licensed in California.

Dmand AI lists amputation, aortic atherosclerois, arterial blot clot /embolism, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), heart device and aorta surgery and leg revascularization among the conditions Dr. Barleben treats.

CMS data shows 543 Medicare services from Dr. Barleben across 10 procedure codes in 2024, for 386 Medicare patients. Medicare paid $19,644 for them.

CMS counts 386 Medicare patients who saw Dr. Barleben in 2024. The largest group is 65 to 74, with 151 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Barleben's median patient age at 67, with 48% women.

In 2019, Dr. Barleben wrote 23 Medicare Part D claims. They cover 1 drug, with $160 in total drug cost. In 2018, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Barleben for performance year 2024, reported as part of a group. Dr. Barleben accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Barleben as offering telehealth.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 63 papers to Dr. Barleben, published from 2007 to 2025. 2020 was the busiest year, with 6. The most frequent topics are Endovascular Procedures, Blood Vessel Prosthesis Implantation and Blood Vessel Prosthesis. Dr. Barleben has published most often in Ann Vasc Surg. Dr. Barleben's most frequent co-authors are Mahmoud Malas, MD, Dennis Francis Bandyk, MD and John Shackelford Lane, MD.

Dmand AI links Dr. Barleben to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Aortic Aneurysm, Abdominal, Aortic Aneurysm and Carotid Stenosis. Endologix sponsors the most, 2.

CMS Open Payments shows 1,470 general payments to Dr. Barleben from 44 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 38% of the total. Endologix, Inc. paid the most, $112,249.

Dmand AI lists 2 awards for Dr. Barleben, most recently CMS Stage 1 EHR in 2013.

Dr. Barleben graduated from New York Medical College in 2005. Dr. Barleben is a member of ACS.

Dr. Barleben is in network with 11 carriers, including Aetna, Excellus BlueCross BlueShield and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.